Why is Applied DNA Sciences, Inc. ?
- Poor long term growth as Operating profit has grown by an annual rate -32.19% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -12.95
- NET PROFIT(HY) At USD -15.41 MM has Grown at -148.94%
- OPERATING CASH FLOW(Y) Lowest at USD -13.61 MM
- NET SALES(HY) At USD 1.59 MM has Grown at -18.88%
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -96.83%, its profits have fallen by -78.7%
- Along with generating -96.83% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Applied DNA Sciences, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Fallen by -102.55% (YoY
Highest at USD -2.12 MM
Highest at USD -2.03 MM
Highest at USD -2.03 MM
Highest at USD -0.68
At USD -15.41 MM has Grown at -148.94%
Lowest at USD -13.61 MM
At USD 1.59 MM has Grown at -18.88%
Lowest at -297.4%
Lowest at USD 4.15 MM
Lowest at 5.99 times
Lowest at 4.22 times
Here's what is working for Applied DNA Sciences, Inc.
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Raw Material Cost as a percentage of Sales
Here's what is not working for Applied DNA Sciences, Inc.
Net Sales (USD MM)
Operating Cash Flows (USD MM)
Net Sales (USD MM)
Cash and Cash Equivalents
Inventory Turnover Ratio
Debtors Turnover Ratio






